There are 2789 resources available
408P - Characteristics of patients with colorectal cancer who underwent surgery for liver metastases and pattern of relapse
Presenter: Manuel Alva Bianchi
Session: ePoster Display
409P - Real-world outcomes from cisplatin versus mitomycin plus fluoropyrimidine and radiation for localized squamous cell carcinoma of the anus (SCCA)
Presenter: Rachel Riechelmann
Session: ePoster Display
430P - Learning from FOCUS4: A molecularly stratified adaptive trial platform in metastatic colorectal cancer
Presenter: Janet Graham
Session: ePoster Display
Resources:
Abstract
431P - The FOCUS4-N trial results and individual patient data meta-analysis (IPDM) of maintenance therapy versus active monitoring for patients with metastatic colorectal cancer (mCRC)
Presenter: Richard Adams
Session: ePoster Display
433P - Durvalumab and tremelimumab in combination with FOLFOX in patients with previously untreated RAS-mutated metastatic colorectal cancer: First results of efficacy at one year for phase II MEDITREME trial
Presenter: Jean-David Fumet
Session: ePoster Display
436P - Phase (Ph) II study of taminadenant (NIR178) + spartalizumab (PDR001) in patients (pts) with microsatellite stable (MSS) colorectal cancer (CRC)
Presenter: Omar Saavedra Santa Gadea
Session: ePoster Display
437P - Quality of life (QoL) in patients (pts) with microsatellite instability (MSI-H) or mismatch repair deficient (dMMR) metastatic colorectal cancer (mCRC) treated with nivolumab (NIVO) alone or in combination with ipilimumab (IPI): CheckMate 142
Presenter: Eric Van Cutsem
Session: ePoster Display